Alvotech Stock-Based Compensation Growth & History (ALVO)
Alvotech's stock-based compensation was $7.4M for fiscal 2025.
View full Alvotech company overviewAlvotech annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.4M | −$248,000 | −3.25% |
| 2024 | 2024-12-31 | $7.6M | −$10.4M | −57.71% |
| 2023 | 2023-12-31 | $18.0M | $7.7M | +74.79% |
| 2022 | 2022-12-31 | $10.3M | $10.3M | — |
| 2021 | 2021-12-31 | $0 | — | — |
Alvotech quarterly stock-based compensation
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $2.9M | $811,000 | +38.44% |
| Q1 2026 | 2026-03-31 | $2.3M | $1.0M | +79.20% |
| Q4 2025 | 2025-12-31 | $1.2M | — | — |
| Q3 2025 | 2025-09-30 | $2.7M | — | — |
| Q2 2025 | 2025-06-30 | $2.1M | — | — |
| Q1 2025 | 2025-03-31 | $1.3M | — | — |
Alvotech stock-based compensation trends
Between the periods ended 2021-12-31 and 2025-12-31, Alvotech's stock-based compensation increased from $0 to $7.4M, a change of $7.4M. The latest reported quarter, Q2 2026, shows $2.9M.
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Alvotech source filings ↗